You are about to leave the Clinical Value website now.


Rethinking the delivery of biologics in the treatment of cancer

Subcutaneous delivery infographic


  1. O’Shaughnessy J, et al. Eur J Cancer 2021;152:223-232;
  2. Bittner B, et al. BioDrugs 2018;32:425–440;
  3. Leveque D. Anticancer Res 2014;34:1579–86;
  4. Anderson KC, et al. Future Oncol 2019;15:3267–3281;
  5. Stoner KL, et al. Patient 2014;8:45–153;
  6. McCloskey C, et al. Pharmacoecon Open 2023;7:3–36;
  7. De Cock E, et al. Value Health 2014;17:A653;
  8. Davies A, et al. Lancet Oncol 2014;15:343–52;
  9. Ismael G, et al. Lancet Oncol 2012;13:869–78;
  10. Usmani SZ, et al. Blood 2016;128:1149;
  11. Badkar AV, et al. Drug Des Devel Ther 2021;15:159–170.

You May Also Like

13 May 2024

No woman left behind: Increasing access to testing for cervical cancer elimination

Read More
13 May 2024

Advancing women’s health: Project Teal drives cervical cancer screening in Hong Kong

Read More


Be the first to receive updates, event opportunities, and thought leadership insights.